NCT07585396CompletedPhase 2/3
Inositol in Letrozol Resistant PCOS Women
Efficacy of Inositol in Managing Subfertility in Letrozole-resistant Polycystic Ovary Syndrome Women
Source: ClinicalTrials.gov · Last updated 29 Sept 2026
Brief summary (registry, in English)
Polycystic ovary syndrome (PCOS),is a complex neuro-endocrine disorder affecting approximately 5% to 10% of women in reproductive age.Inositols are considered insulin sensitizers, as they modulate the members of insulin signaling pathways.Thiss study compares between the effect of inositol and metformin in letrozol resistant PCOS women.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2/3
- Study type
- Interventional
- Enrollment
- 136 (actual)
- First submitted
- 7 May 2026
- Start date
- 10 Apr 2024
- Primary completion date
- 10 Jun 2026
- Lead sponsor
- Kafrelsheikh University
- NCT number
- NCT07585396
What you commit to
- Study type: Interventional · Phase 2/3
- Participants enrolled: 136
- From 10 Apr 2024 to the primary completion date, 10 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • History of ovarian surgery.
- cases associated with endometriosis.
- History of diabetes mellitus.
- Allergy to myo-Inositol .
Who the study is looking for
- • Age between 20- 38 years old.
- Diagnosis of PCOS according to Rotterdam criteria
- Letrozole resistant cases.
- Normal thyroid hormone level.
- Normal prolactin hormone level.
Age in the registry: 20 years to 38 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kafrelshiekh university hospital Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.